Additionally, the 36-month beta value for UPC is 1.59.
The public float for UPC is 8.52M and currently, short sellers hold a 0.65% ratio of that float. The average trading volume of UPC on March 20, 2025 was 12.36M shares.
UPC) stock’s latest price update
Universe Pharmaceuticals INC (NASDAQ: UPC)’s stock price has dropped by -10.20 in relation to previous closing price of 0.10. Nevertheless, the company has seen a loss of -27.15% in its stock price over the last five trading days. globenewswire.com reported 2025-03-20 that Jiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of 40 ordinary shares with par value of US$0.28125 per share each in the Company’s issued and unissued share capital into one (1) ordinary share with par value of US$11.25 (the “Share Consolidation”). As a result of the Share Consolidation, each 40 pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders.
UPC’s Market Performance
Universe Pharmaceuticals INC (UPC) has experienced a -27.15% fall in stock performance for the past week, with a -41.10% drop in the past month, and a -87.06% drop in the past quarter. The volatility ratio for the week is 12.47%, and the volatility levels for the past 30 days are at 16.04% for UPC. The simple moving average for the past 20 days is -30.93% for UPC’s stock, with a -99.51% simple moving average for the past 200 days.
UPC Trading at -68.41% from the 50-Day Moving Average
After a stumble in the market that brought UPC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.86% of loss for the given period.
Volatility was left at 16.04%, however, over the last 30 days, the volatility rate increased by 12.47%, as shares sank -37.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -86.34% lower at present.
During the last 5 trading sessions, UPC fell by -26.57%, which changed the moving average for the period of 200-days by -99.80% in comparison to the 20-day moving average, which settled at $0.1274. In addition, Universe Pharmaceuticals INC saw -85.57% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for UPC
Current profitability levels for the company are sitting at:
- -0.2 for the present operating margin
- 0.27 for the gross margin
The net margin for Universe Pharmaceuticals INC stands at -0.69. The total capital return value is set at -0.19. Equity return is now at value -50.22, with -30.97 for asset returns.
Based on Universe Pharmaceuticals INC (UPC), the company’s capital structure generated 0.2 points at debt to capital in total, while cash flow to debt ratio is standing at -0.93. The debt to equity ratio resting at 0.24. The interest coverage ratio of the stock is -24.75.
Currently, EBITDA for the company is -3.22 million with net debt to EBITDA at 0.15. When we switch over and look at the enterprise to sales, we see a ratio of -0.06. The receivables turnover for the company is 1.86for trailing twelve months and the total asset turnover is 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.63.
Conclusion
In conclusion, Universe Pharmaceuticals INC (UPC) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
